100 related articles for article (PubMed ID: 1809034)
1. Decreased size of peritoneal macrophage during peritonitis in continuous ambulatory peritoneal dialysis patients.
Chen WT; Kobayashi Y; Huang TP; Chiu CC; Lin CY
Am J Nephrol; 1991; 11(5):374-9. PubMed ID: 1809034
[TBL] [Abstract][Full Text] [Related]
2. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
Lin CY; Huang TP
Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
Lin CY; Huang TP
Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
5. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
Lin CY; Lin CC; Huang TP
Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
[TBL] [Abstract][Full Text] [Related]
6. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
7. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
8. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
Lin CY; Ku WL; Huang TP
Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
[TBL] [Abstract][Full Text] [Related]
9. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Horton MW; Deeter RG; Sherman RA
Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium.
Piraino B; Bernardini J; Holley JL; Perlmutter JA
Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027
[TBL] [Abstract][Full Text] [Related]
11. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
13. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
14. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
[TBL] [Abstract][Full Text] [Related]
16. IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD).
Schröder CH; Bakkeren JA; Weemaes CM; Monnens LA
Perit Dial Int; 1989; 9(4):261-5. PubMed ID: 2488378
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor is produced during infectious peritonitis in CAPD patients.
Montrucchio G; Mariano F; Cavalli PL; Tetta C; Viglino G; Emanuelli G; Camussi G
Kidney Int; 1989 Dec; 36(6):1029-36. PubMed ID: 2601253
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
19. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
[TBL] [Abstract][Full Text] [Related]
20. An extracorporeal model of biofilm-adherent bacterial microcolony colonization for the study of peritonitis in continuous ambulatory peritoneal dialysis.
Dasgupta MK; Lam K; Ulan RA; Bettcher KB; Burns V; Tyrrell DL; Dossetor JB; Costerton JW
Am J Nephrol; 1988; 8(2):118-22. PubMed ID: 3293442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]